BG Medicine Profile

USD 0.0058  9.62%

Exercise of in-the-money or at-the-money derivative position by Noubar Afeyan of 1724 shares of BG Medicine

BG Medicine Inc insider trading alert for exercise of common stock by Noubar Afeyan, the corporate stakeholder, on February 12, 2018. This event was filed by Bg Medicine Inc with SEC on 2014-12-05. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

BG Medicine Summary

BG Medicine Inc (BGMD) is traded on OTC Market in USA. It is located in MASSACHUSETTS, U.S.A and employs 5 people. BG Medicine is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Nano-Cap' category with current market capitalization of 742.74 K. BG Medicine Inc conducts business under Healthcare sector and is part of Pharmaceutical Products industry. This company has 11.37 M outstanding shares of which 630.05 K shares are currently shorted by private and institutional investors with about 2.66 trading days to cover. BG Medicine currently holds about 1.52 M in cash with (3.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.14 which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check BG Medicine Probability Of Bankruptcy

Ownership Allocation (%)

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Ifp Advisors IncCommon Shares75.00.0
Agtc Partners LpCommon Shares863.3 K354 K
View BG Medicine Diagnostics

Selected BG Medicine Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

BG Medicine Against Markets

Current Ratings

BG Medicine 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 56% 
Equity ratings for BG Medicine Inc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
BG Medicine, Inc. engages in development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts. BG Medicine operates under Medical Laboratories Research classification in USA and traded on OTC Market. It employs 5 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameBG Medicine Inc
President CEO, DirectorPaul SohmerView All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock View All
RegionNorth America
Business Address303 Wyman Street
ExchangeOTC Market
CIK Number01407038.0
IndustryPharmaceutical Products
Contact Number781 890 1199
CurrencyUSD - US Dollar

Current Sentiment - BGMD

BG Medicine Inc Investor Sentiment
Most of Macroaxis users are currently bullish on BG Medicine Inc. What is your opinion about investing in BG Medicine Inc? Are you bullish or bearish?
98% Bullish
2% Bearish
Skip  Hide


BG Medicine Analyst Recommendations
Target PriceAdvice# of Analysts
BG Medicine Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
BG Medicine Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


BG Medicine Corporate Directors
James Connor Director
Harry Wilcox Director
Stelios Papadopoulos Independent Director, MBA